Banking U44
Revenue Growth Can Mask a Decline in Company Value
A company can grow ARR and still lose value as valuation multiples shift. Founders should weigh buyer demand, financial metrics and the cost of waiting.
More revenue doesn't guarantee a larger exit. A company can hit its growth targets while buyers assign it a lower valuation multiple, leaving its enterprise value below where it stood before. For founders weighing whether to sell or keep building, tracking that value alongside operating performance can clarify what waiting might cost.
That risk came into focus in a conversation with a potential client whose company was performing well. The founder expected further growth over the next couple of years and wanted to realize it before considering a sale. The plan may create value, but growth alone can't establish that it will. The central question is how buyers will assess the business when that growth arrives.
Growth can be outweighed by a lower multiple
Consider a hypothetical software company with $15 million in annual recurring revenue (ARR) and a valuation of 6x ARR. That implies an enterprise value of $90 million. Two years later, ARR has risen to $20 million, but the valuation multiple has fallen to 3.5x revenue. The implied enterprise value is then $70 million.
In this illustration, revenue is up 33%, while enterprise value is down 22%. The figures are assumptions, not a forecast; they show how a lower multiple can outweigh operating growth. A founder who delays a sale to reach a revenue milestone could still face a smaller implied exit value if buyers price the business less generously at that point.
The example also shows why a revenue target can't stand in for a valuation plan. ARR describes the scale of recurring sales. A multiple reflects how buyers judge the durability, quality and future potential of those sales, among other factors. Both can change, and they don't necessarily move in the same direction.
What buyers weigh alongside revenue
Valuation reflects several kinds of evidence. Qualitative factors include the strength of the management team, how much the company depends on its founder, competitive pressure, product differentiation and the business's strategic relevance to potential buyers. These characteristics can affect how confidently a buyer expects the company to operate and grow after a transaction.
Buyers also examine absolute financial measures such as revenue, EBITDA and cash flow. Relative measures provide another perspective: growth rates, margins, net revenue retention and gross revenue retention. Retention percentages matter because they indicate whether customers remain and whether existing accounts expand or contract over time.
Those indicators need to be read together. A company may become larger and more profitable even as its growth rate slows with maturity. Strong retention, improving margins or a deeper management team could support a higher multiple; weaker growth, customer durability or differentiation could weigh on it. The final valuation depends on how buyers balance those signals against relevant peers and their own plans.
For founders and boards, the useful exercise is to identify which qualities are likely to improve over the coming year and which may weaken. That makes the assumptions behind a proposed delay more concrete: Does the operating plan strengthen the business in ways a buyer is likely to value, or does it mainly add revenue while leaving the underlying case unchanged?
Timing depends on both company progress and buyer demand
A sale takes preparation, buyer outreach, negotiation and diligence. Throughout that process, buyers revisit the company's performance and forecasts. A slowdown that becomes visible only after a sale process starts may prompt harder questions about projections and narrow the seller's room to negotiate.
Buyer interest has its own timetable, too. A strategic buyer may see immediate value in a company's technology, customers or geographic reach. That interest could change if the buyer launches an internal product, completes another purchase or revises its budget. The seller may continue to grow while the specific reason a buyer wanted the business becomes less compelling.
There are sound reasons to wait. More scale could attract additional buyers, improved profitability could make the business more attractive, and reduced customer concentration could lower a perceived risk. But these are hypotheses to test against the operating plan, not automatic consequences of postponing a sale.
Put valuation scenarios beside the operating plan
Boards can compare estimated enterprise value with the company's operating plan across several scenarios: revenue grows while the multiple stays flat, rises or falls. That view makes visible how sensitive the outcome is to both performance and buyer pricing. It also helps distinguish a plan that creates more revenue from one that may improve the business's broader appeal.
Enterprise value is only one part of what owners receive. Debt and cash, dilution, liquidation preferences and transaction terms can change proceeds for shareholders. Including those factors keeps a headline valuation from being mistaken for the amount available to owners after a deal.
No one can reliably know the valuation peak in advance. A decision to wait nevertheless carries an assumption about what future growth, margins, retention and buyer appetite will mean for value. Keeping that assumption on the same page as the revenue forecast gives founders and boards a clearer basis for weighing the possible rewards against the cost of delay.
Itay Sagie is a guest contributor to Crunchbase News, a lecturer and adviser to startups and investors on strategy, growth and M&A. Connect with him on LinkedIn.
Related Crunchbase query
Illustration: Dom Guzman
